drugset / Trial / NCT01168414
A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single-center, cross-over comparison parallel group randomized trial designed to evaluate the efficacy and safety of Ganfort compared to Duotrav for a treatment period of 8 weeks each.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-01
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 300 ug | — |
| Subject | Travoprost | Other / unclassified | 40 ug | — |
| Background | Timolol | Other / unclassified | 5 mg/ml | — |